In this study, using a genetic knockout animal model and pharmacological blockade of TNF-α, we show for the first time that attenuation of Ang II mediated hypertension and cardiac hypertrophy by TNF-α inhibition involves decreased oxidative stress and NF-κB activation, and reduced phosphorylation of MAPK. This evidence concerns the gene NFKB1 and hypertensive disorder.